Proteasome (PSMB5)
The cell's protein shredder. Myeloma cells make huge amounts of antibody protein and depend on the proteasome to clear the waste, so blocking it kills them.
Overview
The 26S proteasome degrades ubiquitin-tagged proteins, and its chymotrypsin-like activity sits in the PSMB5 subunit that bortezomib and carfilzomib bind. Plasma cells, and myeloma cells in particular, secrete immunoglobulin at a rate that overloads protein quality control, so proteasome inhibition triggers a terminal unfolded protein response and blocks NF-kB signalling. Bortezomib was approved for myeloma in 2003 and carfilzomib in 2012; peripheral neuropathy is the class toxicity of bortezomib and cardiovascular events of carfilzomib.
- Target · the protein and the cell it sits on
- Drug · antibody, small molecule, cell or radioligand
- Effect · signal, damage or kill
In plain words · The cell's protein shredder. Myeloma cells make huge amounts of antibody protein and depend on the proteasome to clear the waste, so blocking it kills them.
- 1 · What it is
The cell's protein shredder. Myeloma cells make huge amounts of antibody protein and depend on the proteasome to clear the waste, so blocking it kills them.
- 2 · What goes wrong in cancer
Multi-subunit protease complex that degrades ubiquitinated proteins; PSMB5 carries the chymotrypsin-like catalytic activity targeted by approved inhibitors.
- 3 · How drugs use it
No product in this corpus aims at Proteasome (PSMB5) yet. Inhibitors are shaped to fit the enzyme's active site so the reaction the cancer relies on stops.
External identifiers
Biology
Multi-subunit protease complex that degrades ubiquitinated proteins; PSMB5 carries the chymotrypsin-like catalytic activity targeted by approved inhibitors.
- Multiple myeloma
- Mantle cell lymphoma
Latest papers
topQuery for this target: (TITLE:"Proteasome" OR ABSTRACT:"Proteasome" OR TITLE:"PSMB5" OR ABSTRACT:"PSMB5") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Proteasome (PSMB5), not a curated reading list.
Similar pages
not linked directly; found by shared links- PersonSundar Jagannath
Shares Carfilzomib, Bortezomib, Multiple myeloma.
- PersonA. Keith Stewart
Shares Carfilzomib, Multiple myeloma.
- PersonPaul G. Richardson
Shares Bortezomib, Multiple myeloma.
- TrialDREAMM-7
Shares Bortezomib, Multiple myeloma.
- PersonKenneth C. Anderson
Shares Bortezomib, Multiple myeloma.
- TrialCEPHEUS
Shares Bortezomib, Multiple myeloma.
- PathwayB-cell receptor / BTK signalling (to NF-κB)
Shares Bortezomib, Mantle cell lymphoma, Multiple myeloma.
- TermProteasome inhibitor (bortezomib, carfilzomib, ixazomib)
Shares Bortezomib, Multiple myeloma.